Diagnoz.me

Company Overview

Snapshot

Founded in October 2017 by Tamir Epstein and Ariel Livne, Diagnoz.me operated with 1–10 employees. The company secured funding across two rounds, totaling $840,000, to develop its remote diagnostic tool. In November 2017, Diagnoz.me received a grant from the Israel Innovation Authority.

Business overview

Diagnoz.me is developing a remote diagnostic tool designed for detecting and analyzing the microbial content of body fluids. The company's core technology enables a standard smartphone to function as a medical diagnostics microscope when paired with a proprietary, low-cost disposable device. This solution aims to allow patients to conduct at-home tests and receive lab-grade results rapidly, which can then be transmitted directly to physicians for accurate and personalized treatment, serving the digital healthcare and medical device sectors globally.

Strategic signal

In March 2019, Diagnoz.me was featured for its innovative technology that transforms smartphones into medical diagnostic microscopes. This highlights the company's early potential in democratizing access to medical diagnostics and enabling remote healthcare, signaling a strategic validation of its approach to leveraging ubiquitous consumer technology for critical health applications.

Company Intelligence Q&A

What is Diagnoz.me's primary offering?

Diagnoz.me develops a remote diagnostic tool that uses a standard smartphone and a proprietary disposable device to detect and analyze microbial content in body fluids, providing lab-grade results for at-home use.

When was Diagnoz.me founded and by whom?

Diagnoz.me was founded in October 2017 by Tamir Epstein and Ariel Livne.

What was a key early funding event for Diagnoz.me?

In November 2017, Diagnoz.me received a grant from the Israel Innovation Authority to support its development efforts.

What is the total capital raised by Diagnoz.me?

Diagnoz.me has raised a total of $840,000 across two funding rounds.

What was a notable media mention for Diagnoz.me?

In March 2019, Israel21c.org featured Diagnoz.me for its technology that turns a smartphone into a medical diagnostics microscope, emphasizing its potential for remote healthcare.